Royal Philips and N-of-One, Inc., a provider of clinical interpretation of molecular tests in oncology is teaming up to enhance the capabilities of Philips’ IntelliSpace Genomics solution. The two companies will collaborate on the clinical analysis, annotation and interpretation of oncology cases processed through Philips’ new precision medicine solution for oncology.This healthcare informatics solution integrates genomic information with full patient context to empower clinicians with
Read More
N-of-One
N-of-One Raises $7M for Precision Medicine Oncology Decision Support
N-of-One, a precision medicine oncology decision support company has raised $7 million in funding from Providence Ventures and Excel Venture Management. The latest round brings its total funding to $11M. Founded in 2008 by a team of PhD scientists and oncologists, N-of-One analyzes and interprets tumor molecular profiles to help physicians and patients identify diagnostic and treatment strategies from its proprietary database.Working with leading healthcare systems and large commercial labs,
Read More
